257 related articles for article (PubMed ID: 23326462)
1. High levels of adherence and viral suppression in a nationally representative sample of HIV-infected adults on antiretroviral therapy for 6, 12 and 18 months in Rwanda.
Elul B; Basinga P; Nuwagaba-Biribonwoha H; Saito S; Horowitz D; Nash D; Mugabo J; Mugisha V; Rugigana E; Nkunda R; Asiimwe A
PLoS One; 2013; 8(1):e53586. PubMed ID: 23326462
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of nonsuppressed viral load and associated factors among HIV-positive adults receiving antiretroviral therapy in Eswatini, Lesotho, Malawi, Zambia and Zimbabwe (2015 to 2017): results from population-based nationally representative surveys.
Haas AD; Radin E; Hakim AJ; Jahn A; Philip NM; Jonnalagadda S; Saito S; Low A; Patel H; Schwitters AM; Rogers JH; Frederix K; Kim E; Bello G; Williams DB; Parekh B; Sachathep K; Barradas DT; Kalua T; Birhanu S; Musuka G; Mugurungi O; Tippett Barr BA; Sleeman K; Mulenga LB; Thin K; Ao TT; Brown K; Voetsch AC; Justman JE
J Int AIDS Soc; 2020 Nov; 23(11):e25631. PubMed ID: 33225559
[TBL] [Abstract][Full Text] [Related]
3. Socio-Demographic and Adherence Factors Associated with Viral Load Suppression in HIV-Infected Adults Initiating Therapy in Northern Nigeria: A Randomized Controlled Trial of a Peer Support Intervention.
Coker M; Etiebet MA; Chang H; Awwal G; Jumare J; Musa BM; Babashani M; Habib AG; Dakum P; Abimiku AG; Charurat ME; Blattner WA; Eng M; Ndembi N
Curr HIV Res; 2015; 13(4):279-85. PubMed ID: 25845393
[TBL] [Abstract][Full Text] [Related]
4. Detectable HIV Viral Load in Kenya: Data from a Population-Based Survey.
Cherutich P; Kim AA; Kellogg TA; Sherr K; Waruru A; De Cock KM; Rutherford GW
PLoS One; 2016; 11(5):e0154318. PubMed ID: 27192052
[TBL] [Abstract][Full Text] [Related]
5. Self-reported antiretroviral therapy adherence and viral load in criminal justice-involved populations.
Cunningham WE; Nance RM; Golin CE; Flynn P; Knight K; Beckwith CG; Kuo I; Spaulding A; Taxman FS; Altice F; Delaney JA; Crane HM; Springer SA
BMC Infect Dis; 2019 Oct; 19(1):913. PubMed ID: 31664910
[TBL] [Abstract][Full Text] [Related]
6. Patient-level outcomes and virologic suppression rates in HIV-infected patients receiving antiretroviral therapy in Rwanda.
Riedel DJ; Stafford KA; Memiah P; Coker M; Baribwira C; Sebeza J; Karorero E; Nsanzimana S; Morales F; Redfield RR
Int J STD AIDS; 2018 Aug; 29(9):861-872. PubMed ID: 29621951
[TBL] [Abstract][Full Text] [Related]
7. A simple self-reported adherence tool as a predictor of viral rebound in people with viral suppression on antiretroviral therapy.
O'Connor JL; Gardner EM; Esser S; Mannheimer SB; Lifson AR; Telzak EE; Phillips AN;
HIV Med; 2016 Feb; 17(2):124-32. PubMed ID: 26186609
[TBL] [Abstract][Full Text] [Related]
8. High levels of viral load monitoring and viral suppression under Treat All in Rwanda - a cross-sectional study.
Ross J; Ribakare M; Remera E; Murenzi G; Munyaneza A; Hoover DR; Shi Q; Nsanzimana S; Yotebieng M; Nash D; Anastos K;
J Int AIDS Soc; 2020 Jun; 23(6):e25543. PubMed ID: 32536033
[TBL] [Abstract][Full Text] [Related]
9. Retention in care and virological failure among adult HIV+ patients on second-line ART in Rwanda: a national representative study.
Nsanzimana S; Semakula M; Ndahindwa V; Remera E; Sebuhoro D; Uwizihiwe JP; Ford N; Tanner M; Kanters S; Mills EJ; Bucher HC
BMC Infect Dis; 2019 Apr; 19(1):312. PubMed ID: 30953449
[TBL] [Abstract][Full Text] [Related]
10. HIV Viral Load Suppression in Adults and Children Receiving Antiretroviral Therapy-Results From the IeDEA Collaboration.
Jiamsakul A; Kariminia A; Althoff KN; Cesar C; Cortes CP; Davies MA; Do VC; Eley B; Gill J; Kumarasamy N; Machado DM; Moore R; Prozesky H; Zaniewski E; Law M
J Acquir Immune Defic Syndr; 2017 Nov; 76(3):319-329. PubMed ID: 28708808
[TBL] [Abstract][Full Text] [Related]
11. Viral suppression among children and their caregivers living with HIV in western Kenya.
Humphrey JM; Genberg BL; Keter A; Musick B; Apondi E; Gardner A; Hogan JW; Wools-Kaloustian K
J Int AIDS Soc; 2019 Apr; 22(4):e25272. PubMed ID: 30983148
[TBL] [Abstract][Full Text] [Related]
12. Accuracy of self-report of HIV viral load among people with HIV on antiretroviral treatment.
Sewell J; Daskalopoulou M; Nakagawa F; Lampe FC; Edwards S; Perry N; Wilkins E; O'Connell R; Jones M; Collins S; Speakman A; Phillips AN; Rodger AJ;
HIV Med; 2017 Aug; 18(7):463-473. PubMed ID: 28004523
[TBL] [Abstract][Full Text] [Related]
13. Detectable Viral Load in Late Pregnancy among Women in the Rwanda Option B+ PMTCT Program: Enrollment Results from the Kabeho Study.
Gill MM; Hoffman HJ; Bobrow EA; Mugwaneza P; Ndatimana D; Ndayisaba GF; Baribwira C; Guay L; Asiimwe A
PLoS One; 2016; 11(12):e0168671. PubMed ID: 28006001
[TBL] [Abstract][Full Text] [Related]
14. Discordant Treatment Responses to Combination Antiretroviral Therapy in Rwanda: A Prospective Cohort Study.
Kayigamba FR; Franke MF; Bakker MI; Rodriguez CA; Bagiruwigize E; Wit FW; Rich ML; Schim van der Loeff MF
PLoS One; 2016; 11(7):e0159446. PubMed ID: 27438000
[TBL] [Abstract][Full Text] [Related]
15. Rates and Predictors of Non-Adherence to Antiretroviral Therapy among HIV-Positive Individuals in Kenya: Results from the Second Kenya AIDS Indicator Survey, 2012.
Mukui IN; Ng'ang'a L; Williamson J; Wamicwe JN; Vakil S; Katana A; Kim AA
PLoS One; 2016; 11(12):e0167465. PubMed ID: 27907114
[TBL] [Abstract][Full Text] [Related]
16. High viral suppression and low attrition in healthy HIV-infected patients initiated on ART with CD4 above 500 cells/µL in a program setting in Uganda.
Byonanebye DM; Semitala FC; Katende J; Bakenga A; Arinaitwe I; Kyambadde P; Musinguzi P; Biraro IA; Byakika-Kibwika P; Kamya MR
Afr Health Sci; 2020 Mar; 20(1):132-141. PubMed ID: 33402901
[TBL] [Abstract][Full Text] [Related]
17. HIV treatment outcomes following antiretroviral therapy initiation and monitoring: A workplace program in Papua, Indonesia.
Limmade Y; Fransisca L; Rodriguez-Fernandez R; Bangs MJ; Rothe C
PLoS One; 2019; 14(2):e0212432. PubMed ID: 30802257
[TBL] [Abstract][Full Text] [Related]
18. A Markov model for the effects of virological failure on HIV/AIDS progression in tuberculosis co-infected patients receiving antiretroviral therapy in a rural clinic in northern South Africa.
Shoko C; Chikobvu D; Bessong PO
S Afr Med J; 2020 Mar; 110(4):313-319. PubMed ID: 32657744
[TBL] [Abstract][Full Text] [Related]
19. Association between mental disorders with detectable viral load and poor adherence to antiretroviral therapy among adolescents infected with Human Immunodeficiency Virus on follow-up at Chantal Biya Foundation, Cameroon.
Ndongo FA; Kana R; Nono MT; Noah JYA; Ndzie P; Tejiokem MC; Biheng EH; Ndie J; Nkoa TA; Ketchaji A; Ngako JN; Penda CI; Bissek ACZ; Ndombo POK; Hawa HM; Msellati P; Lallemant M; Faye A
J Epidemiol Popul Health; 2024 Apr; 72(2):202193. PubMed ID: 38523399
[TBL] [Abstract][Full Text] [Related]
20. Factors associated with 10 years of continuous viral load suppression on HAART.
Bello KJ; Mesner O; O'Bryan TA; Won SH; Lalani T; Ganesan A; Agan BK; Okulicz JF
BMC Infect Dis; 2016 Jul; 16():351. PubMed ID: 27449671
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]